TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: The primary findings generated from in vitro models include reduced TRPM3 surface expression and ion channel function, as well as increased TRPM2 surface expression in the NK cells of ME/CFS patients [41,42,44,45,46].